| Literature DB >> 23790157 |
François Roubille, Jean-Claude Tardif.
Abstract
INTRODUCTION: Atherosclerosis remains one of the main causes of cardiovascular disease. AREAS COVERED: A brief overview of the work summarized by Berman et al. [Berman JP, Farkouh ME, Rosenson RS. Emerging anti-inflammatory drugs for atherosclerosis. Expert Opin Emerg Drugs 2013;18(2):193-205] on the development of anti-inflammatory drugs to tackle atherosclerosis is provided. EXPERT OPINION: Indeed, recent data from clinical trials on anti-inflammatory drugs in coronary artery disease highlight the potential of such therapies.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23790157 DOI： 10.1517/14728214.2013.811487
Source DB: PubMed Journal: Expert Opin Emerg Drugs ISSN： 1472-8214 Impact factor: 4.191